Neuberger Berman Group’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.6K | Sell |
32,878
-1,121
| -3% | -$1.93K | ﹤0.01% | 1984 |
|
|
2025
Q1 | $113K | Buy |
33,999
+8,879
| +35% | +$29.6K | ﹤0.01% | 1865 |
|
|
2024
Q4 | $186K | Buy |
25,120
+14,716
| +141% | +$109K | ﹤0.01% | 1801 |
|
|
2024
Q3 | $97.7K | Buy |
10,404
+370
| +4% | +$3.47K | ﹤0.01% | 1835 |
|
|
2024
Q2 | $80.5K | Buy |
+10,034
| New | +$80.5K | ﹤0.01% | 1819 |
|
|
2021
Q2 | – | Sell |
-398,484
| Closed | -$12.6M | – | 1784 |
|
|
2021
Q1 | $12.6M | Buy |
398,484
+341,409
| +598% | +$10.8M | 0.01% | 784 |
|
|
2020
Q4 | $2.65M | Sell |
57,075
-53,000
| -48% | -$2.46M | ﹤0.01% | 1057 |
|
|
2020
Q3 | $3.62M | Buy |
110,075
+15,000
| +16% | +$494K | ﹤0.01% | 928 |
|
|
2020
Q2 | $2.61M | Buy |
95,075
+59,975
| +171% | +$1.65M | ﹤0.01% | 956 |
|
|
2020
Q1 | $1.05M | Buy |
+35,100
| New | +$1.05M | ﹤0.01% | 1084 |
|
|
2018
Q3 | – | Sell |
-74,000
| Closed | -$947K | – | 1651 |
|
|
2018
Q2 | $947K | Buy |
+74,000
| New | +$947K | ﹤0.01% | 1245 |
|